• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬脂酰辅酶A去饱和酶抑制作用可阻断丙型肝炎病毒诱导的特殊膜的形成。

Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes.

作者信息

Lyn Rodney K, Singaravelu Ragunath, Kargman Stacia, O'Hara Shifawn, Chan Helen, Oballa Renata, Huang Zheng, Jones Daniel M, Ridsdale Andrew, Russell Rodney S, Partridge Anthony W, Pezacki John Paul

机构信息

1] National Research Council of Canada, Ottawa, Ontario, Canada [2] Department of Chemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.

1] National Research Council of Canada, Ottawa, Ontario, Canada [2] Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.

出版信息

Sci Rep. 2014 Apr 1;4:4549. doi: 10.1038/srep04549.

DOI:10.1038/srep04549
PMID:25008545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4091094/
Abstract

Hepatitis C virus (HCV) replication is dependent on the formation of specialized membrane structures; however, the host factor requirements for the formation of these HCV complexes remain unclear. Herein, we demonstrate that inhibition of stearoyl-CoA desaturase 1 (SCD-1) halts the biosynthesis of unsaturated fatty acids, such as oleic acid, and negatively modulates HCV replication. Unsaturated fatty acids play key roles in membrane curvature and fluidity. Mechanistically, we demonstrate that SCD-1 inhibition disrupts the integrity of membranous HCV replication complexes and renders HCV RNA susceptible to nuclease-mediated degradation. Our work establishes a novel function for unsaturated fatty acids in HCV replication.

摘要

丙型肝炎病毒(HCV)的复制依赖于特殊膜结构的形成;然而,这些HCV复合物形成所需的宿主因子仍不清楚。在此,我们证明抑制硬脂酰辅酶A去饱和酶1(SCD-1)会阻止不饱和脂肪酸(如油酸)的生物合成,并对HCV复制产生负调节作用。不饱和脂肪酸在膜曲率和流动性中起关键作用。从机制上讲,我们证明SCD-1抑制会破坏膜性HCV复制复合物的完整性,并使HCV RNA易受核酸酶介导的降解。我们的工作确立了不饱和脂肪酸在HCV复制中的新功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/3b14f41d75ee/srep04549-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/09583cca32f5/srep04549-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/2fb2f91a6046/srep04549-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/fc6126cdda95/srep04549-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/5bd4d78a6c76/srep04549-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/ce62f4f0ec9c/srep04549-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/8f8e9bdd23f0/srep04549-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/3f5ae51d91f5/srep04549-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/3b14f41d75ee/srep04549-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/09583cca32f5/srep04549-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/2fb2f91a6046/srep04549-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/fc6126cdda95/srep04549-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/5bd4d78a6c76/srep04549-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/ce62f4f0ec9c/srep04549-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/8f8e9bdd23f0/srep04549-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/3f5ae51d91f5/srep04549-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6040/4091094/3b14f41d75ee/srep04549-f8.jpg

相似文献

1
Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes.硬脂酰辅酶A去饱和酶抑制作用可阻断丙型肝炎病毒诱导的特殊膜的形成。
Sci Rep. 2014 Apr 1;4:4549. doi: 10.1038/srep04549.
2
Liver-specific mono-unsaturated fatty acid synthase-1 inhibitor for anti-hepatitis C treatment.用于抗丙型肝炎治疗的肝脏特异性单不饱和脂肪酸合酶-1抑制剂。
Antiviral Res. 2016 Aug;132:262-7. doi: 10.1016/j.antiviral.2016.07.003. Epub 2016 Jul 5.
3
Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replication.硬脂酰辅酶A去饱和酶1与丙型肝炎病毒复制复合体相关并调节病毒复制。
J Virol. 2014 Nov;88(21):12311-25. doi: 10.1128/JVI.01678-14. Epub 2014 Aug 13.
4
Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication.硬脂酰辅酶 A 去饱和酶-1 是黄病毒 RNA 复制所必需的。
Antiviral Res. 2019 May;165:42-46. doi: 10.1016/j.antiviral.2019.03.002. Epub 2019 Mar 7.
5
Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.复杂的脂质代谢重编程是丙型肝炎病毒复制所必需的。
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1041-1056. doi: 10.1016/j.bbalip.2018.06.002. Epub 2018 Jun 6.
6
Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.多不饱和脂肪酸和胆固醇对硬脂酰辅酶A去饱和酶的调节作用。
J Lipid Res. 1999 Sep;40(9):1549-58.
7
Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.癌细胞对不饱和脂肪酸的依赖性表明硬脂酰辅酶 A 去饱和酶是癌症治疗的靶点。
Mol Cancer Res. 2011 Nov;9(11):1551-61. doi: 10.1158/1541-7786.MCR-11-0126. Epub 2011 Sep 27.
8
Atorvastatin decreases stearoyl-CoA desaturase gene expression in THP-1 macrophages incubated with oxidized LDL.阿托伐他汀可降低与氧化型低密度脂蛋白共同孵育的THP-1巨噬细胞中硬脂酰辅酶A去饱和酶基因的表达。
Lipids. 2009 Feb;44(2):115-23. doi: 10.1007/s11745-008-3255-5. Epub 2008 Nov 4.
9
The importance of the stearoyl-CoA desaturase system in octadecenoate metabolism in the Morris hepatoma 7288C.硬脂酰辅酶A去饱和酶系统在莫里斯肝癌7288C中十八碳烯酸代谢中的重要性。
Biochim Biophys Acta. 1985 Jun 30;845(3):380-8. doi: 10.1016/0167-4889(85)90202-2.
10
In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.新型口服小分子硬脂酰辅酶 A 去饱和酶 1 抑制剂 T-3764518 的体内外抗肿瘤活性。
Eur J Pharmacol. 2017 Jul 15;807:21-31. doi: 10.1016/j.ejphar.2017.03.064. Epub 2017 Apr 22.

引用本文的文献

1
Dengue virus is particularly sensitive to interference with long-chain fatty acid elongation and desaturation.登革病毒对长链脂肪酸延长和去饱和的干扰特别敏感。
J Biol Chem. 2025 Mar;301(3):108222. doi: 10.1016/j.jbc.2025.108222. Epub 2025 Jan 23.
2
Glycerophospholipid remodeling is critical for orthoflavivirus infection.甘油磷脂重塑对于黄病毒属病毒感染至关重要。
Nat Commun. 2024 Oct 7;15(1):8683. doi: 10.1038/s41467-024-52979-y.
3
Stearoyl coenzyme A desaturase 1 (SCD1) regulates foot-and-mouth disease virus replication by modulating host cell lipid metabolism and viral protein 2C-mediated replication complex formation.

本文引用的文献

1
Architecture and biogenesis of plus-strand RNA virus replication factories.正链RNA病毒复制工厂的结构与生物发生
World J Virol. 2013 May 12;2(2):32-48. doi: 10.5501/wjv.v2.i2.32.
2
Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle.复制小泡是丙型肝炎病毒生命周期中的负载和阻塞点。
PLoS Pathog. 2013;9(8):e1003561. doi: 10.1371/journal.ppat.1003561. Epub 2013 Aug 22.
3
Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis.丙型肝炎病毒诱导 microRNA-27 的上调:肝脂肪变性的新机制。
硬脂酰辅酶 A 去饱和酶 1(SCD1)通过调节宿主细胞脂质代谢和病毒蛋白 2C 介导的复制复合物形成来调控口蹄疫病毒的复制。
J Virol. 2024 Oct 22;98(10):e0090224. doi: 10.1128/jvi.00902-24. Epub 2024 Sep 26.
4
An Update on the Metabolic Landscape of Oncogenic Viruses.致癌病毒代谢格局的最新进展。
Cancers (Basel). 2022 Nov 23;14(23):5742. doi: 10.3390/cancers14235742.
5
Orsay Virus Infection of Caenorhabditis elegans Is Modulated by Zinc and Dependent on Lipids.秀丽隐杆线虫的奥尔森病毒感染受锌的调节并依赖于脂质。
J Virol. 2022 Nov 23;96(22):e0121122. doi: 10.1128/jvi.01211-22. Epub 2022 Nov 7.
6
Regulatory Role of Phospholipids in Hepatitis C Virus Replication and Protein Function.磷脂在丙型肝炎病毒复制及蛋白功能中的调控作用
Pathogens. 2022 Jan 15;11(1):102. doi: 10.3390/pathogens11010102.
7
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection.过氧化物酶体增殖物激活受体配体在严重急性呼吸综合征冠状病毒2、丙型肝炎病毒和人巨细胞病毒感染期间,通过靶向紊乱的脂质代谢诱导抗病毒作用。
Biology (Basel). 2022 Jan 11;11(1):114. doi: 10.3390/biology11010114.
8
Identification of Differential Responses of Goat PBMCs to PPRV Virulence Using a Multi-Omics Approach.采用多组学方法鉴定山羊 PBMC 对 PPRV 毒力的差异反应。
Front Immunol. 2021 Oct 4;12:745315. doi: 10.3389/fimmu.2021.745315. eCollection 2021.
9
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication.FADS2 依赖性脂肪酸去饱和作用决定了细胞对铁死亡的敏感性和丙型肝炎病毒复制的易感性。
Cell Chem Biol. 2022 May 19;29(5):799-810.e4. doi: 10.1016/j.chembiol.2021.07.022. Epub 2021 Sep 13.
10
Profiling of MicroRNA Targets Using Activity-Based Protein Profiling: Linking Enzyme Activity to MicroRNA-185 Function.基于活性的蛋白质谱分析对 microRNA 靶标的分析:将酶活性与 microRNA-185 功能联系起来。
Cell Chem Biol. 2021 Feb 18;28(2):202-212.e6. doi: 10.1016/j.chembiol.2020.12.009. Epub 2021 Jan 14.
Hepatology. 2014 Jan;59(1):98-108. doi: 10.1002/hep.26634. Epub 2013 Nov 19.
4
Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.膜型丙型肝炎病毒复制区的形态和生化特征。
J Virol. 2013 Oct;87(19):10612-27. doi: 10.1128/JVI.01370-13. Epub 2013 Jul 24.
5
Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication.丙型肝炎病毒复制过程中脂肪酸合酶活性和表达的调节
Chem Biol. 2013 Apr 18;20(4):570-82. doi: 10.1016/j.chembiol.2013.03.014.
6
NIH Image to ImageJ: 25 years of image analysis.NIH 图像到 ImageJ:25 年的图像分析。
Nat Methods. 2012 Jul;9(7):671-5. doi: 10.1038/nmeth.2089.
7
Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.在双吡咯烷系列中发现有效的肝靶向硬脂酰辅酶 A 去饱和酶 (SCD) 抑制剂。
Bioorg Med Chem Lett. 2012 Jan 15;22(2):980-4. doi: 10.1016/j.bmcl.2011.12.002. Epub 2011 Dec 8.
8
Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic system.新型体外药效动力学系统分析丝氨酸蛋白酶抑制剂 MK-4519 抗丙型肝炎病毒的药效动力学。
Antimicrob Agents Chemother. 2012 Mar;56(3):1170-81. doi: 10.1128/AAC.05383-11. Epub 2011 Dec 12.
9
Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy.烟酸类药物:具有临床前抗糖尿病疗效的肝脏靶向 SCD 抑制剂。
Bioorg Med Chem Lett. 2011 Dec 15;21(24):7281-6. doi: 10.1016/j.bmcl.2011.10.040. Epub 2011 Oct 18.
10
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.开发一种肝靶向硬脂酰辅酶 A 去饱和酶(SCD)抑制剂(MK-8245),以建立治疗糖尿病和血脂异常的治疗窗口。
J Med Chem. 2011 Jul 28;54(14):5082-96. doi: 10.1021/jm200319u. Epub 2011 Jun 28.